From: Serum cystatin C and inflammatory factors related to COVID-19 consequences
Biochemical and Inflammatory factors | Lymphopenia-Positive N = 52 | Lymphopenia-Negative N = 73 | P-value |  | |||
---|---|---|---|---|---|---|---|
Cystatin C | 1.20 ± 0.45 | 1.58 ± 1.13 | 0.182 |  | |||
Creatinine | 1.19 ± 0.45 | 1.51 ± 1.04 | 0.216 |  | |||
Ferritin (Per 100) | 7.78 ± 4.42 | 5.16 ± 3.49 | 0.001 |  | |||
NLR | 9.72 ± 5.03 | 3.64 ± 1.20 | < 0.001 |  | |||
LDH (Per 100) | 7.27 ± 3.98 | 6.34 ± 2.39 | 0.468 |  | |||
CRP | 108.75 ± 66.55 | 76.69 ± 45.64 | 0.002 |  | |||
Demographic | |||||||
Age | 63.50 ± 16.92 | 43.69 ± 16.94 | < 0.0011 | ||||
Sex; n (%) | |||||||
 Male | 28(54) | 43(60) | 0.5742 | ||||
 Female | 24(46) | 30(40) | |||||
Positive report for smoking | 14(27) | 29(40) | 0.1372 | ||||
BMI | 27.95 ± 5.51 | 25.19 ± 5.11 | 0.0071 | ||||
Positive report for comorbidities | |||||||
 Diabetic | 17(33) | 14(19) | 0.0852 | ||||
 Hypertension | 18(35) | 16(22) | 0.1162 | ||||
 Dyslipidemia | 18(35) | 16(22) | 0.1162 | ||||
 Cardiovascular disease | 20(38.50) | 9(12) | 0.0012 | ||||
 Asthma | 4(8) | 19(26) | 0.0092 | ||||
 COPD* | 16(31) | 23(31.50) | 0.9302 | ||||
 CKD** | 5(10) | 13(18) | 0.1982 | ||||
 Liver diseases | 6(11.50) | 7(10) | 0.7252 |